Adverse events following vaccination with an inactivated, Vero cell culture-derived Japanese encephalitis vaccine in the United States, 2009

Adverse events following vaccination with an inactivated, Vero cell culture-derived Japanese encephalitis vaccine in the United States, 2009–2012

Published:2015-01 Issue:5 Volume:33 Page:708-712
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Rabe Ingrid B.,Miller Elaine R.,Fischer Marc,Hills Susan L.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference22 articles.

1. Estimated global incidence of Japanese encephalitis: a systematic review;Campbell;Bull World Health Organ,2011

2. Japanese encephalitis in travelers from non-endemic countries, 1973–2008;Hills;Am J Trop Med,2010

3. Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP);Centers for Disease Control and Prevention;MMWR Recomm Rep,2010

4. Ixiaro – summary basis for regulatory action;United States Food and Drug Administration,2009

5. Recommendations for use of a booster dose of inactivated vero cell culture-derived Japanese encephalitis vaccine: advisory committee on immunization practices, 2011;Centers for Disease Control and Prevention;MMWR,2011

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative frequency of specified adverse events following Vero cell culture-derived Japanese encephalitis and Vi capsular polysaccharide typhoid vaccines in U.S. military personnel, July 2011–August 2019;Vaccine;2023-02

2. Vaccines for International Travel;Plotkin's Vaccines;2023

3. Japanese Encephalitis Vaccines;Plotkin's Vaccines;2023

4. A randomized, placebo-controlled, blinded phase 1 study investigating a novel inactivated, Vero cell-culture derived Zika virus vaccine;Journal of Travel Medicine;2022-11-15

5. Adverse events following immunization with the live-attenuated recombinant Japanese encephalitis vaccine (IMOJEV®) in Taiwan, 2017–18;Vaccine;2020-07